Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA Read more about Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 Read more about Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
Lantheus to Present at the Jefferies London Healthcare Conference Read more about Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus Reports Third Quarter 2022 Financial Results Read more about Lantheus Reports Third Quarter 2022 Financial Results
Lantheus to Host Third Quarter 2022 Earnings Conference Call and Webcast on November 3, 2022, at 8:00 a.m. Eastern Time Read more about Lantheus to Host Third Quarter 2022 Earnings Conference Call and Webcast on November 3, 2022, at 8:00 a.m. Eastern Time
Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting Showcased Artificial Intelligence Data Read more about Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting Showcased Artificial Intelligence Data
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease Read more about GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
Lantheus to Present at the Wells Fargo Healthcare Conference Read more about Lantheus to Present at the Wells Fargo Healthcare Conference
